SpectraCure Overview
- Founded
- 2003

- Status
- Public
- Employees
- 13

- Stock Symbol
- SPEC

- Investments
- 1
- Share Price
- $1.20
- (As of Friday Closing)
SpectraCure General Information
Description
SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.
Contact Information
Primary Industry
Therapeutic Devices
Other Industries
Drug Discovery
Biotechnology
Stock Exchange
STO
Primary Office
- Magistratsvägen 10
- 226 43 Lund
- Sweden
+46 046-16 00 00
SpectraCure Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$1.20 | $1.32 | $1.03 - $2.47 | $117M | 97.1M | 589K | -$0.02 |
SpectraCure Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
---|---|---|---|---|
EV | 199,687 | 244,466 | 69,142 | 76,038 |
Revenue | 0 | 0 | 0 | 30 |
EBITDA | (1,304) | (1,211) | (1,088) | (881) |
Net Income | (1,547) | (1,447) | (1,104) | (1,018) |
Total Assets | 23,724 | 10,716 | 7,670 | 1,797 |
Total Debt | 626 | 718 | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
SpectraCure Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore SpectraCure‘s full profile, request access.
Request a free trialSpectraCure Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Johannes Swartling Ph.D | Chief Technology Officer & Technical Manager | ||
Masoud Khayyami Ph.D | Chief Executive Officer & Board Member |
SpectraCure Board Members (5)
Name | Representing | Role | Since |
---|---|---|---|
Ingemar Kihlström | Self | Board Member | 000 0000 |
Katarina Svanberg Ph.D | Self | Advisor & Board Member | 000 0000 |
Masoud Khayyami Ph.D | Self | Chief Executive Officer & Board Member | 000 0000 |
Stefan Andersson-Engels | Self | Board Member | 000 0000 |
Sune Svanberg | Self | Board Member | 000 0000 |
SpectraCure Signals
Growth Rate

0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile

-35.5%.
530%
Size Multiple

219x
Median
Size Multiple
219x, 100th %ile

0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialSpectraCure Investments (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000000000 (0000 | 07-Apr-2008 | 000000000 00000 00 | Buildings and Property |